Sedation for Diagnostic Bronchoscopy. Abnormal findings on diagnostic imaging of lung
Conditions
Interventions
Intervention 1: Intervention group: Remifentanil 0.1 microgram/kg/min Intra venously 3 min Before Procedure plus Propofol 0.5 mg/kg Intra venously. Intervention 2: Intervention group: Remifentanil 0
Treatment - Other
Intervention group: Remifentanil 0.1 microgram/kg/min Intra venously 3 min Before Procedure plus Propofol 0.5 mg/kg Intra venously
Intervention group: Remifentanil 0.1 microgram/kg/min Intra venously 3 min Before Procedure plus Ketamine 0.25 mg/kg Intra venously
Sponsors
Ardabil University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 18 to 65 y/o Patients with Pulmonary Diseases ( ASA : 1_3 ) that selected by Pulmonologist for Diagnostic Bronchoscopy
Exclusion criteria
Exclusion criteria: Patients with Opioid addiction Untreated HTN or IHD Loss of Consciousness Epileptic Patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent of Systolic Blood Pressure Rising after Drugs administeration. Timepoint: Record of Systolic Blood Pressure Before, During and After Procedure. Method of measurement: Non invasive Manometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Consciousness State of Patients. Timepoint: 10 minutes after end of Procedure. Method of measurement: Ramsey Sedation Score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDavood Seifi
Ardabil University of Medical Sciences
Outcome results
None listed